Changes in the midbrain-rostral forebrain dopamine circuitry in the cocaine-exposed primate fetal brain.
To ascertain cocaine's effects in the fetus, we developed a nonhuman primate model in which pregnant monkeys were administered cocaine (3 mg/kg i.m.) or saline four times a day from day 20 through days 40-70 of a 165-day gestation. At the time of cesarean section, plasma levels of cocaine in fetal blood were 231 +/- 70 ng/ml. Fetal brains were examined using immunocytochemistry, in situ hybridization, receptor autoradiography, and nuclease protection assay analysis. No differences were found in the expression of tyrosine hydroxylase and dopamine receptor mRNAs by days 40-45 of gestation. However, by day 60 the midbrain of monkeys exposed to cocaine had significantly reduced expression of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. Moreover, dopamine D1 and D2 receptor mRNAs were significantly elevated in the rostral forebrain as were D1 and D2 receptor binding sites in days 60-70 cocaine-exposed fetuses. Cocaine treatment from day 20 to days 60 and 70 of gestation also significantly increased the mRNA concentrations of dynorphin and enkephalin in the rostral forebrain. These findings suggest that in utero cocaine exposure has profound effects on the developing dopamine neurocircuitry.
Department of Physiology and Pharmacology, Oregon Health Sciences University, Portland 97201, USA.
O K
OK
Rønnekleiv
Y
Y
Fang
W S
WS
Choi
L
L
Chai
D000653:Amniotic Fluid / Q000378:metabolism; D000818:Animals; D001835:Body Weight; D001921:Brain / Q000187:drug effects / Q000196:embryology*; D003042:Cocaine / Q000493:pharmacokinetics / Q000633:toxicity*; D004298:Dopamine / Q000378:metabolism*; D004399:Dynorphins / Q000096:biosynthesis; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D004745:Enkephalins / Q000096:biosynthesis; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D008253:Macaca mulatta; D008636:Mesencephalon / Q000187:drug effects / Q000196:embryology; D008657:Metabolic Clearance Rate; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D011247:Pregnancy; D016548:Prosencephalon / Q000187:drug effects / Q000196:embryology; D012333:RNA, Messenger / Q000096:biosynthesis; D017447:Receptors, Dopamine D1 / Q000096:biosynthesis; D017448:Receptors, Dopamine D2 / Q000096:biosynthesis; D014158:Transcription, Genetic / Q000187:drug effects
D004745:Enkephalins; D012333:RNA, Messenger; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D004399:Dynorphins; D003042:Cocaine; D004298:Dopamine